Concepedia

Sirkka B. Stephan

SB

Statistics

Publications

13

Citations

3.2K

H-Index

12

Active since

2006

Affiliations

Fred Hutch Cancer Center(Current)

University of Washington

University of Washington Medical Center

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Cancer Research Center

Sirkka B. Stephan is an author at Fred Hutch Cancer Center specializing in immunology, cancer immunotherapy, and immunotherapy.

ORCID

Publications per year

2006–2024

13

Publications

13

In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers

Tyrel T. Smith, Sirkka B. Stephan, Howell Moffett et al. · Nature Nanotechnology · 2017 · 753 citations · Full text

, , +15

Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers

Fan Zhang, Neha N. Parayath, Chibawanye Ene et al. · Nature Communications · 2019 · 503 citations · Full text

, , +17

Biopolymer implants enhance the efficacy of adoptive T-cell therapy

Sirkka B. Stephan, Alexandria M. Taber, Ilona Jileaeva et al. · Nature Biotechnology · 2014 · 437 citations · Full text

, , +13

In vitro-transcribed antigen receptor mRNA nanocarriers for transient expression in circulating T cells in vivo

Neha N. Parayath, Sirkka B. Stephan, Amanda Koehne et al. · Nature Communications · 2020 · 415 citations · Full text

, , +17

Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors

Tyrel T. Smith, Howell Moffett, Sirkka B. Stephan et al. · Journal of Clinical Investigation · 2017 · 334 citations · Full text

, , +17

1–5 of 13